HemaSphere (Aug 2023)
PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA
- Yuehua Ding,
- Minqiu Lu,
- Bin Chu,
- Lei Shi,
- Shan Gao,
- Qiuqing Xiang,
- Lijuan Fang,
- Yutong Wang,
- XI Liu,
- Xin Zhao,
- Mengzhen Wang,
- Yuan Chen,
- Sun Kai,
- LI Bao
Affiliations
- Yuehua Ding
- 1 Beijing Jishuitan Hospital, Department of Hematology, China
- Minqiu Lu
- 1 Beijing Jishuitan Hospital, Department of Hematology, China
- Bin Chu
- 1 Beijing Jishuitan Hospital, Department of Hematology, China
- Lei Shi
- 1 Beijing Jishuitan Hospital, Department of Hematology, China
- Shan Gao
- 1 Beijing Jishuitan Hospital, Department of Hematology, China
- Qiuqing Xiang
- 2 Beijing Jishuitan Hospital, Department of Hematology, China
- Lijuan Fang
- 3 Beijing Jishuitan Hospital, Department of Hematology, China
- Yutong Wang
- 3 Beijing Jishuitan Hospital, Department of Hematology, China
- XI Liu
- 3 Beijing Jishuitan Hospital, Department of Hematology, China
- Xin Zhao
- 3 Beijing Jishuitan Hospital, Department of Hematology, China
- Mengzhen Wang
- 3 Beijing Jishuitan Hospital, Department of Hematology, China
- Yuan Chen
- 4 Beijing Jishuitan Hospital, Department of Hematology, China
- Sun Kai
- 1 Beijing Jishuitan Hospital, Department of Hematology, China
- LI Bao
- 2 Beijing Jishuitan Hospital, Department of Hematology, China
- DOI
- https://doi.org/10.1097/01.HS9.0000975328.40621.c2
- Journal volume & issue
-
Vol. 7
p. e40621c2
Abstract
No abstracts available.
